Clinical Trials

Phase 3 Not yet recruiting

546 enrolled

Gastrointestinal

Adenoma, Colonic Neoplasms, Colonic Polyps, Neoplasm Recurrence, Local, Recurrence

NCT07286162 2026-01-27

CALM-TF

300 enrolled

Gynecologic

Ovarian Neoplasms, Recurrence

NCT07363330 2026-01-26

A Phase II Study of Utidelone With Toripalimab in Advanced Cervical Cancer

32 enrolled

Gynecologic

Uterine Cervical Neoplasms, Neoplasm Metastasis, Recurrence

NCT07361666 2026-01-23

HFUS-CLEAR

Not yet recruiting

400 enrolled

Dermatologic

Margins of Excision, Carcinoma, Basal Cell, Carcinoma, Squamous Cell, Recurrence, Skin Neoplasms

NCT07350824 2026-01-20

Predictive Value of Minimal Residual Disease for Postoperative Recurrence and Adjuvant PD-1 Inhibitor in HCC

Phase 3 Not yet recruiting

276 enrolled

Recurrence, Neoplasm, Residual

NCT07342478 2026-01-16

ROCKET-CLL Global Phase 3 Study: Rocbrutinib vs Pirtobrutinib in cBTKi-Pretreated R/R CLL/SLL

306 enrolled

LymphoidOther hematologic neoplasm

Chromosome 17 deletion, Recurrence, Leukemia, B-Cell, Leukemia, Lymphocytic, Chronic, B-Cell

NCT07345741 2026-01-16

Clinical Study on the Safety and Efficacy of CD20/CD19 Cell Injection in the Treatment of Relapsed or Refractory B-cell Non-Hodgkin Lymphoma

28 enrolled

Recurrence, Lymphoma, B-Cell

NCT07347977 2026-01-16

LidCRM

1,400 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Recurrence

NCT07348393 2026-01-16

Mezi-KD

70 enrolled

Plasma cell

Multiple Myeloma, Recurrence

NCT07343934 2026-01-15

huCART19-IL18-eDHFR Cells in Relapsed/Refractory Follicular Lymphoma

6 enrolled

Lymphoma, Follicular, Recurrence

NCT07340164 2026-01-14

TROY

Phase EARLY_PHASE1 Not yet recruiting

116 enrolled

Gynecologic

Ovarian Neoplasms, Recurrence

NCT07330895 2026-01-09

Clinical Study of LV009 Injection in the Treatment of Recurrent/Refractory CD19 Positive Blood Tumors

19 enrolled

Recurrence

NCT07331064 2026-01-09

GABRIEL

15 enrolled

CNS

Diffuse Intrinsic Pontine Glioma, Brain Neoplasms, Glioma, Recurrence, Rhabdoid Tumor

NCT07277777 2026-01-06

125I Seed Brachytherapy Combined With Immunotherapy for Primary, Recurrent, or Metastatic Malignant Tumors

90 enrolled

Neoplasms, Recurrence

NCT07316920 2026-01-06

A Clinical Study of of RN1701 Injection in the Treatment of Relapsed/Refractory B-Cell Lymphomas

19 enrolled

Recurrence, Lymphoma, B-Cell

NCT07319793 2026-01-06

Pre-DLI or Pro-DLI in Relapsed/Refractory Myeloid Neoplasms After HSCT

MyeloidOther hematologic neoplasm

200 enrolled

Myelodysplastic Syndromes, Recurrence, Leukemia, Myeloid, Acute

NCT07316907 2026-01-05

A Clinical Study of Allogenic CD19-CAR-T in the Treatment of R/R B-Cell Hematologic Malignancies

LymphoidOther hematologic neoplasm

12 enrolled

Lymphoma, Recurrence, Hematologic Neoplasms

NCT07306832 2025-12-29

A Study to Assess Adverse Events and How Intravenous (IV) Pivekimab Sunirine Moves Through the Body in Pediatric Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML)

Other hematologic neoplasm

18 enrolled

Recurrence, Leukemia, Myeloid, Acute

NCT07166549 2025-12-24

BaseCAR-01

LymphoidOther hematologic neoplasm

12 enrolled

Cytokine Release Syndrome, Lymphoma, Non-Hodgkin, Recurrence, Leukemia, B-Cell, Lymphoma, B-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07288814 2025-12-17

Mitoxantrone Hydrochloride Liposome and Enlonstobart Combination Treatment in Patients With Relapsed or Refractory Peripheral T Cell Lymphoma (PTCL)

Phase 1/2 Not yet recruiting

43 enrolled

Recurrence, Lymphoma, T-Cell, Peripheral

NCT06970496 2025-11-20

A Clinical Trial of B019 Injection in Patients With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma.

48 enrolled